Your browser doesn't support javascript.
Use of electronic cigarettes and heated tobacco products during the Covid-19 pandemic.
Gallus, Silvano; Stival, Chiara; Carreras, Giulia; Gorini, Giuseppe; Amerio, Andrea; McKee, Martin; Odone, Anna; van den Brandt, Piet A; Spizzichino, Lorenzo; Pacifici, Roberta; Lugo, Alessandra.
  • Gallus S; Department of Environmental Health Sciences, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy. silvano.gallus@marionegri.it.
  • Stival C; Department of Environmental Health Sciences, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.
  • Carreras G; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.
  • Gorini G; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.
  • Amerio A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Psychiatry, University of Genoa, Genoa, Italy.
  • McKee M; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Odone A; Centre for Global Chronic Conditions, London School of Hygiene and Tropical Medicine, London, UK.
  • van den Brandt PA; School of Medicine, University Vita-Salute San Raffaele, Milan, Italy.
  • Spizzichino L; Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
  • Pacifici R; Department of Epidemiology, GROW- School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Lugo A; Department of Epidemiology, CAPHRI- School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, The Netherlands.
Sci Rep ; 12(1): 702, 2022 01 13.
Article in English | MEDLINE | ID: covidwho-1900531
ABSTRACT
Only a few studies investigated changes in electronic cigarette (e-cigarette) and heated tobacco product (HTP) use during pandemic restrictions. We conducted a web-based cross-sectional study of a representative sample of 6,003 Italian adults during the strictest phase of the Covid-19 lockdown (April-May 2020). Participants were asked to report changes in e-cigarette and HTP use compared to before the pandemic. E-cigarette users increased from 8.1% to 9.1% and HTP users from 4.0% to 4.5%. Among e-cigarette non-users before lockdown, 1.8% started using e-cigarettes during lockdown. New users were more frequently younger (p for trend 0.001), men (odds ratio, OR 1.56; 95% confidence interval, CI 1.03-2.34), cannabis users (OR 2.35; 95% CI 1.33-4.13), gamblers (OR 3.34; 95% CI 2.18-5.11) and individuals with anxiety symptoms (OR 1.58; 95% CI 1.00-2.52). 1.0% of HTP non-users started using it during lockdown. New users were less frequently current than never cigarette smokers (OR 0.19; 95% CI 0.06-0.61) and more frequently gamblers (OR 2.23; 95% CI 1.22-4.07). E-cigarettes and HTPs played little role as smoking cessation tools for hardcore smokers but rather provided opportunities for young never smokers to engage in socially acceptable activities, perhaps reflecting the obstacles they faced in obtaining other addictive substances during confinement.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / Tobacco Products / Electronic Nicotine Delivery Systems / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Sci Rep Year: 2022 Document Type: Article Affiliation country: S41598-021-04438-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / Tobacco Products / Electronic Nicotine Delivery Systems / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Sci Rep Year: 2022 Document Type: Article Affiliation country: S41598-021-04438-7